The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 18, 2022

Filed:

Jul. 28, 2017
Applicants:

Itek Ventures Pty Ltd, Salisbury South, AU;

The University of Melbourne, Melbourne, AU;

Central Adelaide Local Health Network Incorporated, Adelaide, AU;

Inventors:

Sarah Elizabeth Heron, Highbury, AU;

Leanne Michelle Dibbens, College Park, AU;

Samuel Frank Berkovic, Melbourne, AU;

Ingrid Eileen Scheffer, Melbourne, AU;

John Charles Mulley, Firle, AU;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2018.01); C12P 19/34 (2006.01); C12Q 1/6883 (2018.01); C07K 14/705 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); G01N 27/447 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6883 (2013.01); C07K 14/47 (2013.01); C07K 14/705 (2013.01); C07K 16/18 (2013.01); G01N 27/447 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/156 (2013.01);
Abstract

The present invention relates to the proline rich transmembrane protein 2 (PRRT2) gene, and the identification of mutations and variations in PRRT2 that give rise to seizure and movement disorders. Accordingly, the present invention provides methods for the diagnosis or prognosis of such disorders by identifying alterations in the PRRT2 gene. Identification of alterations in the PRRT2 gene also enables the identification of subjects with an increased likelihood of having an offspring predisposed to such disorders. The present invention also provides an isolated nucleic acid molecule comprising an alteration in the PRRT2 gene, wherein said alteration produces a seizure and/or movement disorder phenotype. Also provided is an isolated PRRT2 polypeptide that comprises an alteration which produces a seizure and/or movement disorder phenotype. Furthermore, the present invention provides kit for diagnosing or prognosing a seizure and/or movement disorder in a subject, or for identifying a subject with an increased likelihood of having an offspring predisposed to a seizure and/or movement disorder, wherein the kit includes one or more components for testing for the presence of an alteration in the PRRT2 gene in the subject.


Find Patent Forward Citations

Loading…